Patient-Reported Outcomes With Chemoradiotherapy in Treatment of Anal Cancer
Recent research highlights the importance of patient-reported outcome tools as a method of better understanding and addressing adverse events.
Diagnosis & Disease Information
Phase 2 Results: Pembrolizumab Shows Antitumor Activity and a Manageable Safety Profile in Anal Squamous Cell Carcinoma
This single-arm, phase 2 study of pembrolizumab in advanced solid tumor cancers did not limit patient enrollment based on tumor PD-L1 expression level.
Curative Option Identified for Squamous Cell Carcinoma of the Anal Canal With Distant Metastasis
A retrospective review identified a subset of patients with squamous cell carcinoma of the anal canal with distant metastases who respond to extended-field chemoradiation.
Higher Socioeconomic Status Leads to Improved Survival Outcomes in Anal Cancer
A multivariable analysis revealed how median household income influences cancer-specific and overall survival among patients with squamous cell carcinoma of the anus.
HPV and Cancer (Fact Sheet)
This fact sheet examines possible links between human papillomaviruses (HPVs) and cancer.
HPV Vaccination Discussions Need to Focus on Education, Awareness
The top reasons for not initiating HPV vaccination are necessity, safety, and knowledge, rather than a lack of discussions on sexuality.
Nivolumab Shows Promise Against Aggressive Anal Cancer
Clinical trial results are promising for the use of nivolumab to treat squamous cell carcinoma of the anal canal, according to data presented at the 2016 American Association for Cancer Research Annual Meeting.
High-risk HPV Infection Increases Risk for Anal Cancer
Anal cancer is associated with human papillomavirus (HPV) infection, and some women are at increased likelihood of have both diseases.
HPV16 seropositivity relatively common prior to diagnosis of anal cancer
Human papillomavirus (HPV) type 16 (HPV16) seropositivity is relatively common in people prior to receiving a diagnosis of anal cancer.
HPV16 seropositivity common before anal cancer diagnosis
Human papillomavirus type 16 seropositivity is fairly common before an anal cancer diagnosis, according to a study, and seropositivity tends to increase in blood samples drawn closer to time of cancer diagnosis.
- Loading...
Loading...
Loading... 
Loading...